ustransplant.org -- Transplant Statistics Reference Tables

Transplant Statistics: Annual Report : Reference Tables

Table 11.6d

Immunosuppression Use: Antirejection Treatment from Transplant

to One Year Post Transplant, 1991 to 2000

Recipients with Heart Transplants

		Year of Transplant
		1991	1992	1993	1994	1995	1996	1997	1998	1999	2000
Transplants		2,126	2,171	2,297	2,340	2,361	2,342	2,294	2,347	2,187	2,197
Tx with Antirejection Treatments		862	849	946	928	946	844	865	963	902	887
Antibodies	Category Usage	21.6%	23.1%	26.5%	22.6%	20.6%	17.8%	19.3%	21.3%	17.8%	16.2%
	ALG	0.0%	0.0%	0.4%	1.8%	0.4%	0.0%	0.0%	0.0%	0.0%	0.0%
	ATG	0.2%	0.8%	3.6%	7.2%	7.1%	3.8%	5.9%	6.4%	6.2%	4.4%
	NRATG/NRATS	0.0%	0.0%	0.0%	0.4%	0.7%	1.2%	2.0%	0.8%	0.2%	0.0%
	OKT3	21.3%	22.4%	24.0%	16.6%	14.4%	13.7%	13.2%	15.1%	7.4%	5.3%
	Thymoglobulin	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.1%	0.2%	2.0%	3.8%
	Zenapax	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.1%	0.6%	2.5%	2.8%
	Simulect	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.1%	0.8%	2.0%
Corticosteroids	Category Usage	90.3%	91.4%	88.1%	89.3%	92.5%	88.2%	88.4%	88.1%	91.2%	92.2%
	Prednisone	36.4%	37.8%	36.4%	35.9%	32.9%	31.4%	32.1%	37.6%	51.7%	49.3%
	Methylprednisolone	67.4%	67.8%	68.0%	67.8%	74.5%	71.9%	72.3%	67.1%	64.1%	65.1%

Source: OPTN/SRTR Data as of August 1, 2002.

Individual drug percentages will not necessarily add up to the drug category percentages, as patients may be prescribed more than one drug within the same category.

Center-Specific Reports | OPO Reports | National Reports | Data Accuracy | Report Timeline

SRTR Site designed and maintained by Diamond Bullet Design & URREA.